RecruitingPhase 3NCT07654374
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Waterbury, CT · +73 more sites
6 recruiting obesity studies with a site in Waterbury, CT.
Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Waterbury, CT · +73 more sites
Sponsor: Regeneron Pharmaceuticals
Waterbury, CT · +20 more sites
Sponsor: Eli Lilly and Company
New Haven, CT · Waterbury, CT · +78 more sites
Sponsor: Amgen
Waterbury, CT · +70 more sites
Sponsor: Eli Lilly and Company
Waterbury, CT · +40 more sites
Sponsor: Novo Nordisk A/S
Hamden, CT · Waterbury, CT · +17 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.